.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Novartis
UBS
Accenture
AstraZeneca
Express Scripts
McKesson
Merck
Moodys
Federal Trade Commission

Generated: June 27, 2017

DrugPatentWatch Database Preview

Claims for Patent: 5,028,595

« Back to Dashboard

Claims for Patent: 5,028,595

Title: Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
Abstract:A method for treating a subject infected with the AIDS retrovirus without substantial neuropathy by administering 2',3'-dideoxycytidine to the subject at a dose of from 0.001 to 0.05 milligram per kilogram per day.
Inventor(s): Soo; Whaijen (Wyckoff, NJ)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:07/396,197
Patent Claims: 1. A method for treating a subject infected with the AIDS retrovirus without substantial neuropathy comprising administering 2',3'-dideoxycytidine to the subject at a dose of from 0.001 to 0.05 milligram per kilogram per day.

2. The method of claim 1, wherein said 2',3'-dideoxycytidine is administered orally or intravenously.

3. The method of claim 2, wherein said 2',3'-dideoxycytidine is administered orally.

4. The method of claim 3, wherein said 2',3'-dideoxycytidine is administered at a dose of 0.05 milligram per kilogram per day.

5. The method of claim 4, wherein the 2',3'-dideoxycytidine is administered four times a day.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Healthtrust
UBS
Moodys
Cipla
Express Scripts
Fish and Richardson
Chinese Patent Office
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot